Cargando…
Niclosamide suppresses renal cell carcinoma by inhibiting Wnt/β-catenin and inducing mitochondrial dysfunctions
PURPOSE: To investigate the effects of anthelminthic drug niclosamide in renal cell carcinoma (RCC) and the underlying mechanisms of its action. METHODS: The effects of niclosamide on the proliferation and apoptosis of RCC cells were examined in vitro and in vivo by using MTS, colony formation assay...
Autores principales: | Zhao, Juan, He, Qiushan, Gong, Zhimin, Chen, Sen, Cui, Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005241/ https://www.ncbi.nlm.nih.gov/pubmed/27652012 http://dx.doi.org/10.1186/s40064-016-3153-x |
Ejemplares similares
-
Niclosamide Suppresses Cancer Cell Growth By Inducing Wnt Co-Receptor LRP6 Degradation and Inhibiting the Wnt/β-Catenin Pathway
por: Lu, Wenyan, et al.
Publicado: (2011) -
Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt/β-catenin signaling
por: Yin, Lina, et al.
Publicado: (2016) -
Combination therapy of niclosamide with gemcitabine inhibited cell proliferation and apoptosis via Wnt/β-catenin/c-Myc signaling pathway by inducing β-catenin ubiquitination in pancreatic cancer
por: Kang, Hyeon Woong, et al.
Publicado: (2023) -
WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer
por: King, Mandy L., et al.
Publicado: (2014) -
Niclosamide suppresses Hepatoma cell proliferation via the Wnt pathway
por: Tomizawa, Minoru, et al.
Publicado: (2013)